Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · USD
$40.9
-1.02 (-2.4%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first RAPP analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 2B | |
|---|---|---|
| Revenue (ttm) | 20M | |
| Net income (ttm) | -107.3M | |
| EPS (ttm) | -$2.56 | |
| Shares out | 47.8M | |
| Volume | 323,967 | |
| Beta | 0.95 | |
| Price target | $56.7 | +38.6% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 20M
- Net income (ttm)
- -107.3M
- EPS (ttm)
- -$2.56
- Market cap
- 2B
Fair-value bridge
- Current price
- $40.9
Analyst consensus
Recommendation
Strong Buy
Price target
$56.7
+38.6%
In the news
Latest news · RAPP
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 2B
- P/S
- 98.7x
- P/B
- 4.3x
Profitability
- Gross margin
- 34.3%
- Operating margin
- -611.0%
- ROE
- -28.3%
- ROA
- -19.1%
- ROIC
- -19.7%
Balance sheet
- Debt / equity
- 0.02
- Current ratio
- 27.08
- Quick ratio
- 26.64
Trading
- Beta
- 0.95
- Volume
- 323,967
- Dividend yield
- 0.0%